ETF Managers Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.09M | Buy |
|
|||||
|
2022
Q4 | $534K | Sell |
|
|||||
|
2022
Q3 | $691K | Sell |
|
|||||
|
2022
Q2 | $634K | Buy |
|
|||||
|
2022
Q1 | $921K | Buy |
|
|||||
|
2021
Q4 | $750K | Sell |
|
|||||
|
2021
Q3 | $939K | Buy |
|
|||||
|
2021
Q2 | $812K | Sell |
|
|||||
|
2021
Q1 | $542K | Sell |
|
|||||
|
2020
Q4 | $644K | Sell |
|
|||||
|
2020
Q3 | $379K | Buy |
|
|||||
|
2020
Q2 | $242K | Buy |
|